South Korea to mass-produce antibody treatment for coronavirus this month

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on reddit
Share on telegram
Share on whatsapp
South Korea to mass-produce antibody treatment for coronavirus this month

Health researchers are currently analyzing results of the phase 1 trial, which was approved by the drug ministry on July 17.

SEOUL: South Korea plans to mass-produce an antibody treatment of the novel coronavirus later this month, health authorities said Tuesday.

The country’s drug ministry is currently reviewing phase 2/3 clinical tests for the antibody-based treatment and aims to mass-produce commercial antibodies for the novel coronavirus in September, according to Kwon Jun-wook, deputy chief at the Central Disease Control Headquarters.

Health researchers are currently analysing results of the phase 1 trial, which was approved by the drug ministry on July 17.

They also earned approval for the phase 1 study of the treatment in Britain on July 29.

For blood plasma-based treatment, health authorities said the drug ministry approved the phase 2 study of its development on August 20, and six medical institutions, including Samsung Medical Centre and Asan Medical Centre, will verify its effectiveness and safety on COVID-19 patients.

Health authorities added the blood plasma material for the phase 2 trial will begin being produced Tuesday and supply of the substance will be completed in mid-October.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Related News

0
Would love your thoughts, please comment.x
()
x